| Pharmaceutical Manufacturing and Exports | Tablets, capsules, liquids in Betalactum and Non-Betalactum therapeutic segments, contract manufacturing for regulated and emerging markets. | EU GMP, UK MHRA, and TGA Australia certified facilities; robust quality control; long-standing customer relationships; strategic location in Chennai. | Primarily B2B serving pharmaceutical companies in regulated markets such as UK, Australia, and emerging markets in Asia and Africa. | Contract manufacturing for regulated market clients and specialty therapeutic product lines. | 146 | 100 | Revenue from product sales and contract manufacturing exports to multiple countries. | Direct sales and contractual agreements, with recurring orders based on long-term partnerships. | Regulatory accreditations, capacity expansion, new product launches, and global demand for high-quality pharmaceutical formulations. | Raricap, BSF, Molev, Lopih |
